The term sarcopenia was introduced in 1988. The original definition was a “muscle loss” of
the appendicular muscle mass in the older people as measured by dual energy x‐ray …

Sarcopenia is now defined as a decline in walking speed or grip strength associated with
low muscle mass. Sarcopenia leads to loss of mobility and function, falls, and mortality …

Life expectancy is increasing worldwide, with a resultant increase in the elderly population.
Aging is characterized by the progressive loss of skeletal muscle mass and strength–a …

Objectives Sarcopenia, defined as an age-associated loss of skeletal muscle function and
muscle mass, occurs in approximately 6-22% of older adults. This paper presents evidence …

Sarcopenia is defined as an age associated decline in skeletal muscle mass. The
pathophysiology of sarcopenia is multifactorial, with decreased caloric intake, muscle fiber …

Sarcopenia, the age-associated loss of skeletal muscle mass and function, has considerable
societal consequences for the development of frailty, disability, and health care planning. A …

Sarcopenia, an age‐related decline in muscle mass and function, is affecting the older
population worldwide. Sarcopenia is associated with poor health outcomes, such as falls …

As of October 1, 2016, sarcopenia will have its own International Classification of Disease,
Tenth Revision, Clinical Modification (ICD-10-CM). The assigned code will be M62. 84 and …

Human muscle undergoes constant changes. After about age 50, muscle mass decreases at
an annual rate of 1–2%. Muscle strength declines by 1.5% between ages 50 and 60 and by …

Abstract The European Working Group on Sarcopenia in Older People (EWGSOP)
developed a practical clinical definition and consensus diagnostic criteria for age-related …